Ticker Hub
INO — AI Analysis & Sentiment
5 recent AI-generated analyses for INO. Sentiment and confidence insights updated continuously.
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
Positive Phase 3 data for VGX-3100 in China significantly de-risks the program and opens the path for regulatory submission and potential milestone...
May 21, 2026INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
INOVIO's lead drug candidate, INO-3107, faces a critical challenge after the FDA questioned its eligibility for accelerated approval, despite accep...
Mar 12, 2026ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INO
Inovio Pharmaceuticals faces significant downside risk due to an ongoing securities class action lawsuit alleging critical product development and ...
Feb 20, 2026Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact The Gross Law Firm
Inovio Pharmaceuticals faces a class action lawsuit alleging material misrepresentations regarding its core product development, which, combined wi...
Feb 19, 2026Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact Levi & Korsinsky
A class action lawsuit alleging securities fraud poses a significant new risk for Inovio, compounding its already weak financial position and creat...
Feb 18, 2026